79 related articles for article (PubMed ID: 1808414)
1. [Changes of electrocoagulographic parameters and erythrocyte deformability in multiple myeloma patients on various regimens of polychemotherapy].
Bessmel'tsev SS; Katsadze IuL
Klin Med (Mosk); 1991 Nov; 69(11):69-73. PubMed ID: 1808414
[TBL] [Abstract][Full Text] [Related]
2. [The effect of different programs of cytostatic therapy on the blood coagulation and rheological properties in multiple myeloma patients].
Katsadze IuL; Bessmel'tsev SS; Abdulkadyrov KM
Ter Arkh; 1991; 63(7):61-4. PubMed ID: 1788812
[TBL] [Abstract][Full Text] [Related]
3. [Immunological and rheological disorders in multiple myeloma patients].
Abdulkadyrov KM; Bessmel'tsev SS; Liubimova NIu
Ter Arkh; 1991; 63(7):122-6. PubMed ID: 1788790
[TBL] [Abstract][Full Text] [Related]
4. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J
Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
[TBL] [Abstract][Full Text] [Related]
5. [Characteristics of drug resistance of tumor plasmocytes in vitro in patients with multiple myeloma differently responsive to chemotherapy].
Golenkov AK; Trifonova EV; Kataeva EV; Kil'diushevskiĭ AV; Lutskaia TD; Zariad'eva EA; Nazarova IN; Lukashina MN; Zabotina TN; Mikhaĭlova IN; Inshakov AN; Logacheva NP; Baryshnikov AIu
Ter Arkh; 2000; 72(8):38-41. PubMed ID: 11019426
[TBL] [Abstract][Full Text] [Related]
6. Improved survival in multiple myeloma with combination chemotherapy and plasmapheresis.
Wahlin A; Holm J; Nyström L
Haematologia (Budap); 1984; 17(4):465-71. PubMed ID: 6532916
[TBL] [Abstract][Full Text] [Related]
7. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.
Oken MM; Leong T; Lenhard RE; Greipp PR; Kay NE; Van Ness B; Keimowitz RM; Kyle RA
Cancer; 1999 Sep; 86(6):957-68. PubMed ID: 10491521
[TBL] [Abstract][Full Text] [Related]
8. Polychemotherapy (COMP) treatment in myeloma patients. A preliminary report.
Izzi T; Polchi P; Moretti L; Lucarelli G
Haematologica; 1983; 68(3):381-91. PubMed ID: 6411532
[No Abstract] [Full Text] [Related]
9. [Polychemotherapy versus melphalan-prednisone in multiple myeloma].
Leoni P; Salvi A; Brianzoni MF; Centurioni R; Montillo M; Olivieri A
G Clin Med; 1986 Dec; 67(5-6):291-6. PubMed ID: 3609590
[No Abstract] [Full Text] [Related]
10. [Results of polychemotherapy (a VMCP/VCAP program) in multiple myeloma].
Wutke K; Anger G
Z Gesamte Inn Med; 1983 Dec; 38(23):630-3. PubMed ID: 6689459
[TBL] [Abstract][Full Text] [Related]
11. Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma.
Lefrere F; Makke J; Fermand J; Marolleau J; Dal Cortivo L; Alberti C; Mouton V; Benbunan M; Miclea J
Bone Marrow Transplant; 1999 Sep; 24(5):463-6. PubMed ID: 10482928
[TBL] [Abstract][Full Text] [Related]
12. [Polychemotherapy in multiple myeloma. The COMPA protocol].
Vázquez-Villegas V; Delgado Lamas JL; Romero-García F; Rodríguez-Carrillo J; Medina-Ruiz F
Rev Invest Clin; 1989; 41(4):345-50. PubMed ID: 2698501
[TBL] [Abstract][Full Text] [Related]
13. Combined alpha-2C-interferon/VMCP polychemotherapy versus VMCP polychemotherapy as induction therapy in multiple myeloma: a prospective randomized trial.
Scheithauer W; Cortelezzi A; Fritz E; Kührer I; Polli E; Baldini L; Ludwig H
J Biol Response Mod; 1989 Apr; 8(2):109-15. PubMed ID: 2659740
[TBL] [Abstract][Full Text] [Related]
14. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
15. Comparison of melphalan and prednisone with vincristine, carmustine, melphalan, cyclophosphamide, and prednisone in the treatment of multiple myeloma: results of Eastern Cooperative Oncology Group Study E2479.
Oken MM; Harrington DP; Abramson N; Kyle RA; Knospe W; Glick JH
Cancer; 1997 Apr; 79(8):1561-7. PubMed ID: 9118039
[TBL] [Abstract][Full Text] [Related]
16. [The efficacy of polychemotherapy programs in treating multiple myeloma patients].
Bessmel'tsev SS; Abdulkadyrov KM; Rukavitsyn OA
Ter Arkh; 1998; 70(7):46-9. PubMed ID: 9742636
[TBL] [Abstract][Full Text] [Related]
17. [The influence of verapamil on platelet function in patients with multiple myeloma].
Sokołowska B; Dmoszyńska A; Walter-Croneck A; Wojtaszko M
Pol Merkur Lekarski; 1997 Feb; 2(8):109-10. PubMed ID: 9538652
[TBL] [Abstract][Full Text] [Related]
18. Rate of M-component changes and plasma cell labeling index in 25 patients with multiple myeloma treated with peptichemio.
Riccardi A; Montecucco C; Danova M; Ucci G; Merlini G; Ascari E
Cancer Treat Rep; 1985 Sep; 69(9):971-5. PubMed ID: 4028038
[TBL] [Abstract][Full Text] [Related]
19. Combination of pamidronate and thalidomide in the therapy of treatment-resistant multiple myeloma.
Ciepłuch H; Baran W; Hellmann A
Med Sci Monit; 2002 Apr; 8(4):PI31-6. PubMed ID: 11951079
[TBL] [Abstract][Full Text] [Related]
20. [Combined treatment, polychemotherapy and amino-hydroxybutylidene-diphosphonate, of a patient with multiple myeloma: remission and long survival].
Attardo-Parrinello G; Merlini G; Crema F; Fiorentini ML; Mazzone A; Cotti-Piccinelli E
Medicina (Firenze); 1988; 8(3):318-20. PubMed ID: 3231044
[No Abstract] [Full Text] [Related]
[Next] [New Search]